Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tiziana Life Sciences Plc ADR (TLSA)

Tiziana Life Sciences Plc ADR (TLSA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 146,932
  • Shares Outstanding, K 97,306
  • Annual Sales, $ 0 K
  • Annual Income, $ -26,130 K
  • 60-Month Beta 0.97
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.24
Trade TLSA with:

Options Overview Details

View History
  • Implied Volatility 210.37%
  • Historical Volatility 92.56%
  • IV Percentile 80%
  • IV Rank 24.30%
  • IV High 599.85% on 07/19/21
  • IV Low 85.35% on 05/06/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 62
  • Volume Avg (30-Day) 145
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 801
  • Open Int (30-Day) 776

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4700 +6.80%
on 09/27/21
2.1000 -25.24%
on 09/02/21
-0.0700 (-4.27%)
since 08/27/21
3-Month
1.4600 +7.53%
on 08/23/21
2.5000 -37.20%
on 07/01/21
-0.9300 (-37.20%)
since 06/25/21
52-Week
1.4600 +7.53%
on 08/23/21
5.4400 -71.14%
on 10/08/20
-1.9200 (-55.01%)
since 09/25/20

Most Recent Stories

More News
Precision (DTIL) Inks Deal With Tiziana for Cancer Candidate

Precision (DTIL) signs an exclusive license agreement with Tiziana to explore the latter's fully human anti-CD3 mAb, foralumab, for treating various cancer indications. Stock up.

CRVS : 7.67 (+12.79%)
SPRO : 19.47 (+3.95%)
TLSA : 1.5700 (+3.97%)
DTIL : 12.58 (-0.40%)
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Tesla, Inc. (NASDAQ:TSLA) Investigation

NEW YORK, NY / ACCESSWIRE / August 16, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tesla, Inc. ("Tesla" or the "Company") (NASDAQ:TSLA). Investors...

TLSA : 1.5700 (+3.97%)
TSLA : 791.36 (+2.19%)
Tiziana Life Sciences plc Invites You to Join Us at the Q3 Virtual Investor Summit

London, United Kingdom--(Newsfile Corp. - August 16, 2021) - (NASDAQ:TLSA) today announced that Dr. Kunwar Shailubhai, CEO & CSO will be attending the Q3 Virtual Investor Summit.

TLSA : 1.5700 (+3.97%)
TILS.LN : 51.200 (-4.30%)
Tiziana (TLSA) Posts Positive Data on Nasal COVID-19 Antibody

Tiziana (TLSA) reports positive data from a study investigating its anti-CD3 human monoclonal antibody, foralumab (nasally administered) for treating COVID-19 patients in Brazil. Shares up.

GILD : 70.41 (-1.10%)
INCY : 69.26 (+0.38%)
LLY : 226.40 (-2.28%)
TLSA : 1.5700 (+3.97%)
Fuse Cobalt Corporate Update and President's Letter to Shareholders

(via TheNewswire)

FUSE.VN : 0.075 (+15.38%)
FUSEF : 0.0580 (+6.03%)
TSLA : 791.36 (+2.19%)
GLEN.LN : 336.550 (+1.83%)
TLSA : 1.5700 (+3.97%)
Tiziana Life's (TLSA) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Tiziana Life Sciences (TLSA).

TLSA : 1.5700 (+3.97%)
Repligen (RGEN) Hits Fresh High: Is There Still Room to Run?

Repligen (RGEN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

RGEN : 307.37 (-4.92%)
BMY : 59.84 (-0.65%)
OSMT : 2.98 (+3.47%)
TLSA : 1.5700 (+3.97%)
Global Lithium-Ion Power Battery Market Size Projected to Reach $100 Billion By 2025

, /PRNewswire/ -- In the global lithium-ion power battery market, recent reports on total revenue numbers differ in size, but they agree that future revenues will increase and project a significant rise...

LACDF : 7.3698 (-0.81%)
FUSE.VN : 0.075 (+15.38%)
FUSEF : 0.0580 (+6.03%)
TLSA : 1.5700 (+3.97%)
GLNCY : 9.2500 (+2.89%)
NETE : 9.19 (+1.77%)
LAC : 22.31 (+3.62%)
LAC.TO : 28.14 (+3.19%)
Fuse Cobalt Provides a Corporate Update

(via TheNewswire)

WCTXD : 0.0659 (+26.73%)
FUSEF : 0.0580 (+6.03%)
TLSA : 1.5700 (+3.97%)
FUSE.VN : 0.075 (+15.38%)
Company News for Mar 12, 2020

Companies In The News Are: TLSA, VIR, HEAR, CDMO

T : 27.40 (+1.00%)
BA : 224.16 (+1.25%)
DKS : 130.82 (-0.42%)
OXY : 30.19 (+7.44%)
HEAR : 30.38 (+0.90%)
CAN : 6.02 (-1.47%)
CDMO : 21.25 (-3.72%)
TLSA : 1.5700 (+3.97%)
VIR : 45.04 (+2.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Tiziana Life Sciences PLC is a biotechnology company. It focuses on the clinical development for the treatment of cancers, chronic inflammatory and autoimmune neurodegenerative disorders. The company's product pipeline consists of Foralumab TZLS-401 and Milciclib TZLS-201 which are in clinical stage....

See More

Key Turning Points

3rd Resistance Point 1.7367
2nd Resistance Point 1.6633
1st Resistance Point 1.6167
Last Price 1.5700
1st Support Level 1.4967
2nd Support Level 1.4233
3rd Support Level 1.3767

See More

52-Week High 5.4400
Fibonacci 61.8% 3.9196
Fibonacci 50% 3.4500
Fibonacci 38.2% 2.9804
Last Price 1.5700
52-Week Low 1.4600

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar